NCT07502820
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07502820
Title The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER (POWER)
Acronym POWER
Recruitment Not yet recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Karolinska Institutet
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE


No variant requirements are available.